PharmStockPharmacy Stock

Montair
Montair

2.4
Used to address allergy relief, this generic medicine blocks chemical receptors in the airway. Reduces seasonal sensitivity to airborne particles by preventing bronchial constriction.
Ingredient
Montelukast
Category
Allergy Relief
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Montelukast sodium
Reference Brand
Montelukast
Product Origin
Generic Brand
Product Manufacturer
Cipla Ltd
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Leukotriene Receptor Antagonist
Pharmacological Class
Antiasthmatic/Antiallergic
Manufacturer Description
Intended to relieve allergic bronchoconstriction to support easy respiration and target seasonal allergen sensitivity.
Mechanism of Action
Selectively blocks cysteinyl leukotriene receptors, resolving local airway hyperreactivity and mucosal edema.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
24 hours
Contraindications
Severe hypersensitivity to montelukast
Severe Adverse Events
Neuropsychiatric events — requires immediate medical attention, Systemic eosinophilia — requires immediate medical attention
Common Side Effects
Headache, Nausea, Cough
Uncommon Side Effects
Sinusitis, Abdominal pain, Fatigue
Drug Interactions
Phenobarbital, Rifampin
Pregnancy Safety Warnings
TGA Category B: Safety established in clinical trials. Breastfeeding: Compatible.
Age Restrictions
Approved for pediatric and adult populations.
Storage Guidelines
Store below 25°C.
Related Products
Singulair
Information related to Montair is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to order Bladder Health AU - Betmiga Australia